Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

UK vs LXEH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

LXEH Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 6–1 Matrix Metrics)

LXEH Overall Winner 6-Pillar Tally: UK 0 – 4 LXEH (2 Tie) Matrix Metrics: UK 1 – 6 LXEH

As of Nov 20, 2026, Lixiang Education Holding Co., Ltd. (LXEH) is the stronger overall head-to-head candidate over Ucommune International Ltd (UK) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UK carries a Unified Composite Score of 41.3/100 (SELL) at $1.10 (N/M Forward P/E, -146.0% operating margin), whereas LXEH carries 54.0/100 (HOLD) at $1.39 (N/M Forward P/E, -103.1% operating margin).

  • Technical & Structure Timing Caution: UK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.9); meanwhile LXEH trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About UK vs LXEH
UK NASDAQ
Ucommune International Ltd Ordinary Shares
Services-Business Services, Nec
$1.10
-9.84% 1D
Market Cap $827,100
TTM Revenue $26M
Forward P/E N/M
Beta / 30D Vol 7.12β · 83% Vol
Unified Composite Score
41.3 / 100 SELL
Tech 25.0 Fund 51.0 Flow 50.0 Mom 65.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.8%), weak momentum, RSI 23
RSI-14: 22.9 · SMA20: $1.56 · SMA50: $1.79
LXEH NASDAQ Head-to-Head Winner
Lixiang Education Holding Co., Ltd. American Depositary Shares
Services-Educational Services
$1.39
-5.76% 1D
Market Cap $2.8M
TTM Revenue $31M
Forward P/E N/M
Beta / 30D Vol -1.59β · 59% Vol
Unified Composite Score
54.0 / 100 HOLD
Tech 55.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 47.7 · SMA20: $1.37 · SMA50: $1.51

6-Pillar Scorecard Institutional Category Breakdown (UK 0 – 4 LXEH)

Columns: Metric · UK · LXEH
1. Valuation Multiples LXEH
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.1x
2. Growth & Scale LXEH
Revenue Growth (YoY) -45.4% -0.8%
Earnings Growth (YoY) +0.0% -22.5%
TTM Revenue (USD) $26M $31M
Market Cap $827,100 $2.8M
3. Profitability & Quality LXEH
Gross Margin -2.9% -13.7%
Operating Margin -146.0% -103.1%
Net Profit Margin -144.9% 0.0%
Return on Equity (ROE) -26.1% -57.7%
4. Balance Sheet & Cash Flow LXEH
Cash Generation (TTM) -$35M EBITDA -$26M EBITDA
Cash Flow Margin -133.6% EBITDA Mgn -84.9% EBITDA Mgn
Net Cash / Leverage $42.15 Book/Sh · -26.1% ROE $11.08 Book/Sh · -57.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Real Estate Services Operator Education & Training Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: UK (1) vs LXEH (6)
Institutional Metric UK LXEH Criterion Row Edge
Market Capitalization
Scale
$827,100 $2.8M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-45.4% -0.8% Higher Growth LXEH
Operating Margin (TTM)
Profitability
-146.0% -103.1% Higher Margin LXEH
Net Profit Margin
Profitability
-144.9% 0.0% Higher Margin LXEH
Return on Equity (ROE)
Capital Efficiency
-26.1% -57.7% Higher ROE UK
52-Week Range Position
Momentum
15% ($0–$6) 53% ($0–$2) Stronger Trend LXEH
Beta / 30D Volatility
Risk Regime
7.12β · 83% Vol -1.59β · 59% Vol Lower Realized Risk LXEH
Unified Institutional Score
Composite Signal
41.3 / 100 (SELL) 54.0 / 100 (HOLD) Higher Composite LXEH
Trailing 12M Revenue (USD)
Operating Scale
$26M $31M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-2.9% -13.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$35M EBITDA ($42.15 Book/Sh · -26.1% ROE) -$26M EBITDA ($11.08 Book/Sh · -57.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon LXEH +34.44 pp
UK: -40.2% · LXEH: -5.76%
3M Horizon LXEH +28.96 pp
UK: -49.07% · LXEH: -20.11%
6M Horizon LXEH +54.89 pp
UK: -62.84% · LXEH: -7.95%
1Y Horizon LXEH +277.19 pp
UK: +10.0% · LXEH: +287.19%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UK vs LXEH. Trailing 12-month operating profitability (UK -146.0% vs LXEH -103.1%) and valuation multiples (UK N/M vs LXEH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

UK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$26M
Gross Margin-2.9%
Op. Margin-146.0%
ROE / Fwd P/E-26.1% · N/M
LXEH ADR TTM Benchmark FX-Normalized USD
TTM Revenue$31M
Gross Margin-13.7%
Op. Margin-103.1%
ROE / Fwd P/E-57.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
UK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact UK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LXEH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LXEH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
UK Moat Profile Cyclical / Execution-Driven Positioning
Real Estate Services Operator
Competes within the Real Estate Services value chain with $827,100 market capitalization and -146.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
LXEH Moat Profile Cyclical / Execution-Driven Positioning
Education & Training Services Operator
Competes within the Education & Training Services value chain with $2.8M market capitalization and -103.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ UK vs LXEH Key Questions & Quantitative Answers

As of Nov 20, 2026, Lixiang Education Holding Co., Ltd. (LXEH) is the stronger overall head-to-head candidate over Ucommune International Ltd (UK) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UK carries a Unified Composite Score of 41.3/100 (SELL) at $1.10 (N/M Forward P/E, -146.0% operating margin), whereas LXEH carries 54.0/100 (HOLD) at $1.39 (N/M Forward P/E, -103.1% operating margin). Technical & Structure Timing Caution: UK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.9); meanwhile LXEH trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

LXEH leads the Growth & Scale pillar: UK posts -45.4% YoY revenue growth and +0.0% YoY earnings growth on $26M TTM revenue (-2.9% gross margin, -146.0% operating margin), compared with LXEH at -0.8% YoY revenue growth and -22.5% YoY earnings growth on $31M TTM revenue (-13.7% gross margin, -103.1% operating margin). On trailing 12-month operating scale, UK generates $26M in USD-normalized revenue versus $31M for LXEH. In operating R&D and SG&A reinvestment, UK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LXEH.

LXEH screens cheaper on headline valuation multiples. UK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-133.6% EBITDA margin), whereas LXEH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-84.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UK (-26.1% ROE) versus LXEH (-57.7% ROE) capital efficiency.

In options market volatility and institutional positioning, UK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (7.12β · 83% Vol realized risk). By comparison, LXEH carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.59β · 59% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.